A detailed history of Black Rock Inc. transactions in Si Bone, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,923,160 shares of SIBN stock, worth $50.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,923,160
Previous 3,907,197 0.41%
Holding current value
$50.7 Million
Previous $82 Million 21.69%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$15.15 - $21.58 $241,839 - $344,481
15,963 Added 0.41%
3,923,160 $64.2 Million
Q4 2023

Feb 13, 2024

BUY
$15.75 - $21.38 $8.21 Million - $11.1 Million
521,459 Added 15.4%
3,907,197 $82 Million
Q3 2023

Nov 13, 2023

BUY
$20.22 - $27.36 $6.96 Million - $9.42 Million
344,203 Added 11.32%
3,385,738 $71.9 Million
Q2 2023

Aug 11, 2023

BUY
$19.39 - $28.9 $5.64 Million - $8.41 Million
291,111 Added 10.58%
3,041,535 $82.1 Million
Q1 2023

May 12, 2023

SELL
$12.71 - $21.17 $907,786 - $1.51 Million
-71,423 Reduced 2.53%
2,750,424 $54.1 Million
Q4 2022

Feb 13, 2023

BUY
$11.23 - $19.44 $885,597 - $1.53 Million
78,860 Added 2.87%
2,821,847 $38.4 Million
Q3 2022

Nov 14, 2022

SELL
$12.2 - $18.71 $495,417 - $759,775
-40,608 Reduced 1.46%
2,742,987 $47.9 Million
Q2 2022

Aug 12, 2022

BUY
$12.05 - $22.74 $893,531 - $1.69 Million
74,152 Added 2.74%
2,783,595 $36.7 Million
Q1 2022

May 12, 2022

BUY
$18.32 - $23.03 $176,696 - $222,124
9,645 Added 0.36%
2,709,443 $61.2 Million
Q4 2021

Feb 10, 2022

BUY
$18.75 - $24.8 $5.7 Million - $7.54 Million
304,050 Added 12.69%
2,699,798 $60 Million
Q3 2021

Nov 09, 2021

BUY
$19.65 - $31.89 $327,349 - $531,255
16,659 Added 0.7%
2,395,748 $51.3 Million
Q2 2021

Aug 11, 2021

BUY
$29.4 - $35.96 $69.9 Million - $85.6 Million
2,379,089 New
2,379,089 $74.9 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $444M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.